Keyphrases
Academic Laboratory
20%
Advocacy Groups
20%
CARES Act
20%
Clinical Setting
20%
Clinical Trials
20%
Drug Approval
20%
Duchenne muscular Dystrophy
40%
Exon Skipping
20%
Family Advocacy
20%
Lessons Learned
20%
Muscle Physiology
20%
Muscular Dystrophy
20%
Myotonic Dystrophy
20%
Neuromuscular Disease
100%
New Proposal
20%
Partial Support
20%
Patient's Family
20%
Skeletal muscle
100%
Spinal muscular Atrophy
40%
Toxic RNA
20%
Translational Science
20%
Medicine and Dentistry
Clinical Trial
20%
Diseases
100%
Duchenne Muscular Dystrophy
40%
Exon Skipping
20%
Muscular Dystrophy
20%
Myotonic Dystrophy
20%
Neuromuscular Disease
100%
Skeletal Muscle
100%
Spinal Muscular Atrophy
40%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
20%
Diseases
100%
Drug Approval
20%
Duchenne Muscular Dystrophy
40%
Muscular Dystrophy
20%
Myotonic Dystrophy
20%
Neuromuscular Disease
100%
Spinal Muscular Atrophy
40%